TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.50$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow MNKD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-44.7% -551.5% -135.4% -140.4% -43.2% -81.8% -80.9% 17.1% 14.9% 5.2%
2.4% 30.0% 6.1% 3.4% 5.1% 7.3% 6.3% 2.9% 3.2% 3.5%
2.9% 41.3% 24.6% 9.8% 10.0% 16.2% 13.5% 8.9% 7.5% 6.9%
-39.3% 182.6% 18.8% 1.4% 46.7% 32.9% 10.9%
-79.7% 234.8% 131.7% -19.6% -15.0% -23.5% -24.1% 7.4% -12.8% -24.7%
0.7% 9.7% 1.3% 4.1% 7.3% 15.2% 7.6% 21.3% 3.4% 1.3%
-0.6% 142.0% -0.8% -36.2% 23.4% -200.9% 4.9% -1.0% -33.9% -87.3%
0.0% 0.0% 1.0% 22.8% 0.7%
-0.1% -1.1% 243.7% 1.0% 1.0% -0.7% 19.5% -5.1% -0.9%
-2.9% 131.4% -23.7% 101.0% 22.8% 235.5% 0.0% -3.4% -46.6% 93.1%
24.6% 626.3% 220.0% 110.8% 76.5% 358.2% 21.5% 68.7% -48.1% 90.3%
-20.7% 216.8% 83.7% -65.8% 56.7% 75.6% -54.5% 84.8% -67.0% 8.2%
-45.3% -551.5% -136.7% -144.4% -50.5% -97.0% -88.5% -4.2% 11.5% 3.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?